Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: A systematic review and meta-analysis

Keyphrases

• Meta-analysis 100%
• Systematic Meta-analysis 100%
• Community-acquired Pneumonia 100%
• Proton Pump Inhibitor Therapy 100%
• Proton Pump Inhibitors 75%
• Hospitalization 8%
• High Risk 8%
• Age Groups 8%
• Morbidity Mortality 8%
• Prescription Drugs 8%
• Common Cause 8%
• Subgroup Analysis 8%
• Group by 8%
• First Month 8%
• MEDLINE 8%
• Embase 8%
• CINAHL 8%
• Randomized Controlled Trial 8%
• Cochrane Central Register of Controlled Trials 8%
• Alternative Regimens 8%
• 18 Years Old 8%
• Therapy Initiation 8%
• Web of Science 8%
• Pneumonia Detection 8%
• Hospitalization Risk 8%
• Scopus 8%
• Healthcare Expenditure 8%
• Trial Reporting 8%
• Case-crossover 8%

Medicine and Dentistry

• Outpatient 100%
• Meta-Analysis 100%
• Systematic Review 100%
• Community-Acquired Pneumonia 100%
• Proton-Pump Inhibitor 100%
• Randomized Controlled Trial 6%
• Subgroup Analysis 6%
• Case-Control Study 6%
• Primary Outcome 6%
• Cohort Studies 6%

Pharmacology, Toxicology and Pharmaceutical Science

• Community Acquired Pneumonia 100%
• Proton Pump Inhibitor 100%
• Case-Control Study 6%
• Cohort Study 6%
• Randomized Controlled Trial 6%